HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
Recruiting · NCT06515314 · Registry updated 2025-12-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 1 | 2025-12-02 | NCT06515314 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Ruiliyuan Biotechnology Co., Ltd. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhongshan Hospital Affiliated to Fudan University | Shanghai | China | 10 |